Generics
Driving Access to Affordable, High-Quality Medicines
At BP Clinical, we support the development and approval of generic medicines that meet the same standards of safety, efficacy, and quality as their branded counterparts. Our expertise in bioequivalence studies, regulatory strategy, and clinical operations helps pharmaceutical companies bring cost-effective treatments to market faster — without compromising on scientific integrity.
What Are Generic Medicines?
Generic drugs contain the same active ingredients, dosage form, route of administration, and strength as brand-name drugs. They are rigorously tested to ensure:
By offering affordable alternatives, generics expand healthcare access and reduce the financial burden on patients and health systems worldwide.
Therapeutic Segments Covered
We support generic development across multiple categories:
